Showing results (321-330 of 334) with videos related to
Sort By:
Pageof 34
Heart (British Cardiac Society)|July 16, 2004
Dynamic changes of gene expression profiles during postnatal development of the heart in miceH-W Chen, S-L Yu, W-J Chen, et al.Genomics|August 29, 1998
Profiling expression patterns and isolating differentially expressed genes by cDNA microarray system with colorimetry detectionJ J Chen, R Wu, P C Yang, et al.Allergy|November 19, 2016
Forkhead box protein-3 (Foxp3)-producing dendritic cells suppress allergic responseX-Y Liu, L-Z Xu, X-Q Luo, et al.Contrast Media & Molecular Imaging|December 1, 2018
Manganese-Enhanced T1 Mapping in the Myocardium of Normal and Infarcted HeartsN B Spath, D M L Lilburn, G A Gray, et al.Allergy|July 19, 2017
Long-term effects: Galectin-1 and specific immunotherapy for allergic responses in the intestineL-T Yang, Q Shu, X-Q Luo, et al.Biologicals : Journal of the International Association of Biological Standardization|February 20, 2002
Synthetic peptide-based vaccine and diagnostic system for effective control of FMDC Y Wang, T Y Chang, A M Walfield, et al.Oncogene|April 12, 2016
HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanismsC-H Chen, W-H Chang, K-Y Su, et al.Cell Death and Differentiation|September 7, 2018
Correction to: CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradationC-C Chang, M-H Yang, B-R Lin, et al.Cell Death and Differentiation|November 24, 2012
CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradationC-C Chang, M-H Yang, B-R Lin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2010
A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancerE-H Tan, R Ramlau, A Pluzanska, et al.Pageof 34